As we age, joint pain often becomes an unwelcome companion, limiting our mobility and affecting our quality of life. For many ...

Supplements are widely used to manage joint pain, but the science on their effectiveness is limited. Here's what to know ...

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

The FDA has approved cosibelimab ... The most common side effects were tiredness, muscle or joint pain, an underactive thyroid, diarrhea, constipation, nausea, headache, rash, reactions where ...

17, 2024 -- The FDA last week approved Nemluvio for treating moderate ... for treating atopic dermatitis as headache, muscle and joint pain, and hives (itchy red rashes). The company advises ...

Vertex Pharmaceuticals has a new drug called suzetrigine that it says is nonaddictive and would offer an alternative to painkillers such as oxycodone. The company’s application is pending before the ...

Here are five drug recalls the FDA reported in December: ...

KTVZ News has an update Friday on our previous reports about the sometimes tragic results from use of Librela, a once-monthly ...